Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Perks

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
Human Reproduction (Oxford, England)|December 3, 2003
Prolactin acts as a potent survival factor against C2-ceramide-induced apoptosis in human granulosa cellsC M Perks, P V Newcomb, M Grohmann, et al.
British Journal of Cancer|June 24, 2004
Prolactin acts as a potent survival factor for human breast cancer cell linesC M Perks, A J Keith, K L Goodhew, et al.
Endocrine-Related Cancer|December 10, 2015
Hyperglycaemia-induced chemoresistance in breast cancer cells: role of the estrogen receptorL Zeng, H A Zielinska, A Arshad, et al.
Oncogene|September 6, 2011
Insulin-like growth factor-binding protein-1 (IGFBP-1) regulates human schwannoma proliferation, adhesion and survivalS Ammoun, M C Schmid, L Zhou, et al.
British Journal of Cancer|June 27, 2002
Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cellsC McCaig, C A Fowler, N J Laurence, et al.
Carcinogenesis|March 29, 2003
Transcriptional upregulation of the insulin-like growth factor binding protein IGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma-derived epithelial cellsT J Collard, M Guy, A J Butt, et al.
British Journal of Cancer|April 14, 2011
Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxelC C Uzoh, J M P Holly, K M Biernacka, et al.
Journal of Cellular Biochemistry|September 5, 2002
Evidence implicating a mid-region sequence of IGFBP-3 in its specific IGF-independent actionsA D Hollowood, C E H Stewart, C M Perks, et al.
Plos Medicine|January 3, 2023
Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation studySi Fang, James Yarmolinsky, Dipender Gill, et al.
The American Journal of Clinical Nutrition|December 2, 2000
Alterations in growth and body composition during puberty. IV. Energy intake estimated by the youth-adolescent food-frequency questionnaire: validation by the doubly labeled water methodS M Perks, J N Roemmich, M Sandow-Pajewski, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
Human Reproduction (Oxford, England)|December 3, 2003
Prolactin acts as a potent survival factor against C2-ceramide-induced apoptosis in human granulosa cellsC M Perks, P V Newcomb, M Grohmann, et al.
British Journal of Cancer|June 24, 2004
Prolactin acts as a potent survival factor for human breast cancer cell linesC M Perks, A J Keith, K L Goodhew, et al.
Endocrine-Related Cancer|December 10, 2015
Hyperglycaemia-induced chemoresistance in breast cancer cells: role of the estrogen receptorL Zeng, H A Zielinska, A Arshad, et al.
Oncogene|September 6, 2011
Insulin-like growth factor-binding protein-1 (IGFBP-1) regulates human schwannoma proliferation, adhesion and survivalS Ammoun, M C Schmid, L Zhou, et al.
British Journal of Cancer|June 27, 2002
Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cellsC McCaig, C A Fowler, N J Laurence, et al.
Carcinogenesis|March 29, 2003
Transcriptional upregulation of the insulin-like growth factor binding protein IGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma-derived epithelial cellsT J Collard, M Guy, A J Butt, et al.
British Journal of Cancer|April 14, 2011
Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxelC C Uzoh, J M P Holly, K M Biernacka, et al.
Journal of Cellular Biochemistry|September 5, 2002
Evidence implicating a mid-region sequence of IGFBP-3 in its specific IGF-independent actionsA D Hollowood, C E H Stewart, C M Perks, et al.
Plos Medicine|January 3, 2023
Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation studySi Fang, James Yarmolinsky, Dipender Gill, et al.
The American Journal of Clinical Nutrition|December 2, 2000
Alterations in growth and body composition during puberty. IV. Energy intake estimated by the youth-adolescent food-frequency questionnaire: validation by the doubly labeled water methodS M Perks, J N Roemmich, M Sandow-Pajewski, et al.
Pageof 18